In other sensory systems, such as the retina, PARP1 gene knock-out increases resistance to retinal degeneration (Sahaboglu et al., 2010), and PARP inhibitors, including the anti-cancer drug olaparib, improve retinal viability (Sahaboglu et al., 2016). This evidence concerns the gene PARP1 and retinal degeneration.